Sources and control of impurity during one-pot enzymatic production of dehydroepiandrosterone
- PMID: 38951177
- PMCID: PMC11217079
- DOI: 10.1007/s00253-024-13221-3
Sources and control of impurity during one-pot enzymatic production of dehydroepiandrosterone
Abstract
Dehydroepiandrosterone (DHEA) has a promising market due to its capacity to regulate human hormone levels as well as preventing and treating various diseases. We have established a chemical esterification coupled biocatalytic-based scheme by lipase-catalyzed 4-androstene-3,17-dione (4-AD) hydrolysis to obtain the intermediate product 5-androstene-3,17-dione (5-AD), which was then asymmetrically reduced by a ketoreductase from Sphingomonas wittichii (SwiKR). Co-enzyme required for KR is regenerated by a glucose dehydrogenase (GDH) from Bacillus subtilis. This scheme is more environmentally friendly and more efficient than the current DHEA synthesis pathway. However, a significant amount of 4-AD as by-product was detected during the catalytic process. Focused on the control of by-products, we investigated the source of 4-AD and identified that it is mainly derived from the isomerization activity of SwiKR and GDH. Increasing the proportion of glucose in the catalytic system as well as optimizing the catalytic conditions drastically reduced 4-AD from 24.7 to 6.5% of total substrate amount, and the final yield of DHEA achieved 40.1 g/L. Furthermore, this is the first time that both SwiKR and GDH have been proved to be promiscuous enzymes with dehydrogenase and ketosteroid isomerase (KSI) activities, expanding knowledge of the substrate diversity of the short-chain dehydrogenase family enzymes. KEY POINTS: • A strategy of coupling lipase, ketoreductase, and glucose dehydrogenase in producing DHEA from 4-AD • Both SwiKR and GDH are identified with ketosteroid isomerase activity. • Development of catalytic strategy to control by-product and achieve highly selective DHEA production.
Keywords: DHEA; Impurity control strategy; Ketosteroid isomerase activity; Promiscuous enzymes.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Bioconversion of 4-androstene-3,17-dione to androst-1,4-diene-3,17-dione by recombinant Bacillus subtilis expressing ksdd gene encoding 3-ketosteroid-Δ1-dehydrogenase from Mycobacterium neoaurum JC-12.J Steroid Biochem Mol Biol. 2013 May;135:36-42. doi: 10.1016/j.jsbmb.2012.12.016. Epub 2013 Jan 6. J Steroid Biochem Mol Biol. 2013. PMID: 23298646
-
Efficient 9α-hydroxy-4-androstene-3,17-dione production by engineered Bacillus subtilis co-expressing Mycobacterium neoaurum 3-ketosteroid 9α-hydroxylase and B. subtilis glucose 1-dehydrogenase with NADH regeneration.Springerplus. 2016 Jul 29;5(1):1207. doi: 10.1186/s40064-016-2871-4. eCollection 2016. Springerplus. 2016. PMID: 27516945 Free PMC article.
-
Whole-genome and enzymatic analyses of an androstenedione-producing Mycobacterium strain with residual phytosterol-degrading pathways.Microb Cell Fact. 2020 Oct 2;19(1):187. doi: 10.1186/s12934-020-01442-w. Microb Cell Fact. 2020. PMID: 33008397 Free PMC article.
-
Effects of DHEA on metabolic and endocrine functions of adipose tissue.Horm Mol Biol Clin Investig. 2013 Aug;14(2):65-74. doi: 10.1515/hmbci-2013-0009. Horm Mol Biol Clin Investig. 2013. PMID: 25436721 Review.
-
Dehydroepiandrosterone metabolism.J Endocrinol. 1996 Sep;150 Suppl:S125-7. J Endocrinol. 1996. PMID: 8943796 Review.
References
-
- Anna F, Siegfried QM, Chandra GSS, Reddy AS, Reddy PS, Reddy DNK, Upadhya T, Vilas D (2014) Process for the preparation of dehydroepiandrosterone and its intermediates
-
- Conradt D, Schätzle MA, Husain SM, Müller M. Diversity in reduction with short-chain dehydrogenases: tetrahydroxynaphthalene reductase, trihydroxynaphthalene reductase, and glucose dehydrogenase. ChemCatChem. 2015;7(19):3116–3120. doi: 10.1002/cctc.201500605. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
